CALL FOR PAPER SPECIAL ISSUE OF 2022
European Journal of Biology
Call for Paper for the Special Issue of 2022
European Journal of Biology (Eur J Biol) is an international, scientific, open access journal of Istanbul University, published since 1940. The journal is covered in SCOPUS, Zoological Record, DOAJ, TUBITAK ULAKBIM TR Index, Chemical Abstratcs Service (CAS), CAB Abstracts, CABI (AgBiotechNet Database, Animalscience Database, VetMed Resource, Environmental Impact Database, Horticultural Science Database, Nutrition and Food Sciences Database) and EBSCO Central & Eastern European Academic Source.
The Journal has identified the theme of its 2022 special issue as "The aspects of cellular signalling pathways of different disease models including cancer, rare diseases, metabolic syndrome, and neurological disorders". This special issue is seeking articles that would provide new insights into the molecular, cellular therapeutics and molecules with novel mechanisms which possess a remarkable potential to increase the therapeutic efficiency of current treatment modalities. You are kindly invited to propose research or review articles on cellular biology. Signalling pathways are essential mechanisms for cell differentiation, proliferation, death and response to cellular environments. According to omic study results, the important new insights about different pathways and the molecular and cellular responses of these pathways could be clarified. Submissions with an emphasis on emerging approaches, such as genomics, transcriptomics, proteomics, lipidomics, metabolomics, and glycomics are also welcome.
Information for Manuscript Submission
Manuscripts should be submitted online at https://dergipark.org.tr/en/login
Submitted manuscripts should not have been published previously and should not be under consideration for publication elsewhere. All manuscripts are thoroughly refereed through a double-blind peer-review process. Information for the editorial principles and rules for manuscript preparation is available at
Manuscripts can be submitted up till August 30, 2022.